
Histology And Cytology Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Description
Histology And Cytology Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Summary
Histology And Cytology consists of reagents and test kits used in tissue and cell typing techniques. GlobalData's Medical Devices sector report, “Histology And Cytology Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update provides comprehensive information about the Histology And Cytology pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
The Histology And Cytology report provides key information and data related to:
Extensive coverage of the Histology And Cytology under development
Review details of major pipeline products which include product description, licensing and collaboration details and other developmental activities including pipeline territories, regulatory paths, and estimated approval dates
Reviews of major players involved in the pipeline product development.
Provides key clinical trial data related to ongoing clinical trials such as trial phase, trial status, trial start and end dates, and the number of trials of the major Histology And Cytology pipeline products.
Review of Recent Developments in the segment / industry
The Histology And Cytology report enables you to:
Access significant competitor information, analysis, and insights to improve your R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
Identify and understand important and diverse types of Histology And Cytology under development
Formulate market-entry and market expansion strategies
Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
The GlobalData Differentiation
This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.
The data and analysis within this report are driven by GlobalData Medical Intelligence Center (GDMIC) database. GDMIC gives you the key information required to drive sales, investment and deal-making activity in your business. It includes the following:
- 15,000+ data tables showing market size across more than 780 medical equipment segments and 39 countries, from 2015 and forecast to 2025
- 6,700+ industry-leading analysis reports covering sector reports, medipoint reports, country analysis, expert insights and industry analysis (devices and procedures) reports
- 64,000+ medical equipment company profiles
- 5,600+ company profiles of medical equipment manufacturers in China and India
- 2,200+ company profiles of medical equipment manufacturers in Japan
- 1,200+ companies’ revenue splits and market shares
- 1,600+ quarterly and annual medical equipment company financials
- 850+ medical equipment company SWOTs
- 28,000+ pipeline product profiles
- 56,400+ marketed product profiles
- 47,000+ clinical trials
- 41,500+ trial investigators
- 7,000+ reports on companies with products in development
- 44,000+ deals in the medical equipment industry
- 1,100+ surgical and diagnostic procedures by therapy area
- 50+ key healthcare indicators by country
- 431,000+ Themes Content Items
- 600+ Influencers
- 1,900+ Analysts & Researchers
- 0.5m+ Community Members
- 141,000+ Macroeconomic Indicators
- 1,013,000+ City Indicators
- Extensive coverage of the Histology And Cytology under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Histology And Cytology and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
- Identify and understand important and diverse types of Histology And Cytology under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date
Table of Contents
123 Pages
- About GlobalData
- Histology And Cytology Overview
- Histology And Cytology - Pipeline Products by Stage of Development
- Histology And Cytology - Pipeline Products by Segment
- Histology And Cytology - Pipeline Products by Territory
- Histology And Cytology - Pipeline Products by Regulatory Path
- Histology And Cytology - Pipeline Products by Estimated Approval Date
- Histology And Cytology - Ongoing Clinical Trials
- Histology And Cytology Companies - Pipeline Products by Stage of Development
- Histology And Cytology - Companies Pipeline Products by Stage of Development
- Acousys Biodevices Inc Company Overview
- Agilent Technologies Inc Company Overview
- American Association for the Advancement of Science Company Overview
- Amerimmune LLC Company Overview
- Applikate Technologies LLC Company Overview
- Arizona State University Company Overview
- Becton Dickinson and Co Company Overview
- Boston College Company Overview
- Boston University Company Overview
- Cytoastra LLC Company Overview
- Eta Diagnostics Inc Company Overview
- Indiana University Company Overview
- Kinetic River Corp Company Overview
- Microsensor Labs LLC Company Overview
- NanoCellect Biomedical, Inc. Company Overview
- North Carolina State University Company Overview
- Seed Partners Ltd Company Overview
- SpikImm SAS Company Overview
- Standard BioTools Inc Company Overview
- Sysmex Corp Company Overview
- The University of Manchester Company Overview
- TU Dortmund University Company Overview
- Ubiquitin Biotechnology (Zhejiang) Co Ltd Company Overview
- University of Arkansas Company Overview
- University of California Company Overview
- University of California Los Angeles Company Overview
- University of Colorado Company Overview
- University of New Mexico Company Overview
- University of Washington Company Overview
- US Naval Research Laboratory Company Overview
- VeraPulse LLC Company Overview
- Yale University Company Overview
- Nov 13, 2023: Harvard Apparatus Regenerative Technology Reports Third Quarter 2023 Financial Results
- Nov 09, 2023: Harvard Apparatus Regenerative Technology Schedules Conference Call and Webcast for Q3 2023 Results
- Nov 09, 2023: BeiGene Continues Global Growth with Third Quarter 2023 Financial Results and Business Updates
- Oct 31, 2023: GE HealthCare Reports Third Quarter 2023 Financial Results
- Oct 20, 2023: BioPorto to Host Third Quarter 2023 Earnings Webcast and Analyst Call
- Oct 17, 2023: BD Names Greg Rodetis as Senior Vice President of Investor Relations
- Oct 04, 2023: Boston University Names Melissa L. Gilliam 11th President
- Sep 20, 2023: Cytek Biosciences Cell Analysis Solutions Take Center Stage at Upcoming Clinical Conferences in the US and Europe
- Sep 14, 2023: Cytek Biosciences Launches Educational Roadshow Focused on Spectral Flow Cytometry
- Sep 07, 2023: Veracyte Names Marie-Claire Taine, Ph.D., as General Manager of Its IVD Business Unit To Advance Global Expansion of the Company's Tests
- Sep 06, 2023: Arne Hauge Joins Bio-Works as Chief Financial Officer
- Sep 04, 2023: Grifols names Dr. Jorg Schüttrumpf Chief Scientific Innovation Officer
- Aug 31, 2023: Abcam Reports Earnings Results for the Half Year Ended June 30, 2023
- Aug 29, 2023: SSY Announces 2023 Interim Results
- Aug 29, 2023: Bio-Rad Launches First StarBright Red Dye and Extends Range of Antibody Markers Conjugated to StarBright Dyes to Enhance Multiplex Flow Cytometry and Research Capabilities
- Aug 23, 2023: MDxHealth Reports Q2 and Half Year 2023 Results
- Aug 23, 2023: BD to Present at Investor Healthcare Conferences
- Aug 09, 2023: Harvard Apparatus Regenerative Technology Schedules Conference Call and Webcast for Q2 2023 Results
- Aug 02, 2023: BeiGene Accelerates Global Momentum with Strong Second Quarter 2023 Financial Results
- Jul 27, 2023: F. Hoffmann-La Roche Announces Half Year Results 2023
- Jun 14, 2023: Standard BioTools to Participate in Upcoming Investor Conferences
- Jun 08, 2023: Aridis Pharmaceuticals Announces First Quarter 2023 Financial Results and Business Update
- Jun 07, 2023: Eckert & Ziegler Strahlen Annual General Meeting Approves Dividend of EUR 0.50 per Share
- Jun 01, 2023: Orchard Software, Emerus partner for Point-of-Care testing excellence
- May 30, 2023: Abcam announces statement on calling an extraordinary general meeting
- May 26, 2023: Novacyt Announces Publication of Annual Report and AGM voting
- May 18, 2023: BD launches World's first spectral cell sorter with high-speed cell imaging
- May 18, 2023: Standard BioTools announces NGS Library Preparation as an Upgrade on the X9 High- Throughput Genomics System
- May 17, 2023: ABCAM Result of Annual General Meeting
- May 17, 2023: Abcam: Statement on potential extraordinary general meeting
- May 15, 2023: Standard BioTools Appoints Jeffrey Black as Chief Financial Officer
- May 10, 2023: BioPorto announces interim results for the first three months of 2023
- May 09, 2023: Grifols delivers strong first quarter financials with 23% revenue growth and an adjusted EBITDA margin above guidance of 21%
- May 09, 2023: Standard BioTools reports Q1 2023 financial results
- May 09, 2023: GE HealthCare Names James Saccaro Vice President and Chief Financial Officer
- May 04, 2023: BeiGene announces unaudited results for the three months ended March 31, 2023
- Apr 27, 2023: Veracyte announces five abstracts providing molecular insights into prostate and other cancers to be presented at the 2023 ASCO Annual Meeting
- Apr 25, 2023: Standard BioTools announces conference call and webcast for first quarter 2023 financial results
- Apr 20, 2023: Cytek Biosciences to report Q1 2023 financial results on May 9, 2023
- Apr 20, 2023: QIAGEN announces expansion of supervisory board
- Apr 18, 2023: Juntendo University, Sysmex, and ThinkCyte collaborate to advance the early detection and treatment of blood cancer
- Apr 10, 2023: Biostage Appoints Ron Packard to Board of Directors
- Apr 05, 2023: Notice convening the Annual General Meeting in BioPorto A/S
- Mar 30, 2023: Abcam Publication of 2022 Annual Report and Accounts and Notice of Annual General Meeting
- Mar 28, 2023: SSY Group Announces Annual Net Profit $1.123B, Up 42.9%; Final Div 8 Cents
- Mar 15, 2023: Standard BioTools Announces Appointment of Fenel Eloi to Board of Directors
- Mar 15, 2023: Veracyte Announces Three Abstracts to Be Presented at AACR Annual Meeting 2023
- Mar 07, 2023: Cytek Biosciences introduces new 20-Color AML panel
- Mar 03, 2023: Grifols Announces Full Year 2022 Earnings
- Mar 02, 2023: TeraPore Technologies Raises $10M in Funding
- Mar 01, 2023: Biostage Announces Chairman and CEO Transition
- Feb 22, 2023: Thomas Glanzmann new Grifols Executive Chairman, after Steven F. Mayer resignation
- Feb 22, 2023: MDxHealth to Present Fourth Quarter and Full Year 2022 Financial Results on March 8, 2023
- Feb 14, 2023: Standard BioTools Reports Fourth Quarter and Full Year 2022 Financial Results and Provides 2023 Business Outlook
- Feb 09, 2023: Sysmex Announces Summary of Consolidated Financial Results for the First Nine Months of the Fiscal Year Ending March 31, 2023
- Feb 08, 2023: Sysmex Corp. Notice of Changes in Representative Directors
- Feb 07, 2023: Cytek Biosciences partners with Bio-Rad to expand reagent portfolios
- Feb 07, 2023: Cytek Biosciences to Report Fourth Quarter and Full Year 2022 Financial Results on February 28, 2023
- Feb 07, 2023: QIAGEN Exceeds Outlook for Fourth Quarter and Full-Year 2022 With 14% CER Sales Growth in FY 2022 From Non-COVID Product Groups
- Feb 02, 2023: F. Hoffmann-La Roche Announces Financial Results for fiscal 2022
- Jan 31, 2023: Standard BioTools Announces Conference Call and Webcast for Fourth Quarter and Full Year 2022 Financial Results
- Jan 30, 2023: GE HealthCare Reports Fourth Quarter and Full Year 2022 Financial Results
- Jan 17, 2023: GE HealthCare to Announce Fourth Quarter and Full Year 2022 Results on January 30, 2023
- Jan 10, 2023: GE HealthCare Announces Preliminary Fourth Quarter and Full Year 2022 Revenue Results; Introduces 2023 Outlook
- Jan 09, 2023: Standard BioTools Provides Preliminary Fourth Quarter 2022 Revenue and Business Update
- Jan 06, 2023: BD Announces Webcast of Annual Meeting of Shareholders
- Jan 04, 2023: SSY Group Limited : Voluntary announcement update on business development
- Jan 03, 2023: Standard BioTools Announces Appointment of Betsy Jensen as Chief Human Resources Officer
- Dec 28, 2022: SSY Group Appointment of Independent Non-executive Director and Change in the Composition of Board Committees
- Dec 20, 2022: Eckert & Ziegler Announces Changes in the Supervisory Board
- Dec 19, 2022: Eckert & Ziegler Announces Changes in the Management Board
- Dec 13, 2022: Thomas Schinecker replaces Severin Schwan as Roche's new CEO
- Dec 08, 2022: BD Releases 2022 Global Inclusion, Diversity and Equity Annual Report
- Dec 05, 2022: BioPorto adds Mr. Nis Kruse as EVP of Strategic Partnerships and GM of EMEA & APAC
- Nov 21, 2022: Aridis Pharmaceuticals Announces Third Quarter 2022 Financial Results and Business Update
- Methodology
- About GlobalData
- Contact Us
- Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.